Royalty Pharma PLC
(FRA:RPD)
€
24.8
-0.21 (-0.84%)
Market Cap: 11.22 Bil
Enterprise Value: 16.75 Bil
PE Ratio: 10.45
PB Ratio: 1.73
GF Score: 78/100 Royalty Pharma PLC at Bank of America Global Healthcare Conference (Virtual) Transcript
May 12, 2021 / 01:30PM GMT
Release Date Price:
€35
(+4.79%)
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst
Okay. Good morning. Welcome to the second day of the Bank of America Virtual Vegas Healthcare Conference. My name is Geoff Meacham. I'm the senior biopharma analyst here, and I have Bill Maughan from my team with me as well.
We're thrilled to have Royalty Pharma presenting here. And speaking on behalf of Royalty, we have Chief Financial Officer, Terry Coyne; and Executive VP of -- and Co-Head of Research and Investment, Marshall Urist. Welcome, guys.
Terrance Coyne
Royalty Pharma plc - Executive VP & CFO
Thanks, Geoff. Thanks for having us.
Geoffrey Christopher Meacham;Terrance Coyne
BofA Securities, Research Division - Research Analyst;Royalty Pharma plc - Executive VP & CFO
Yes. Sure. So the -- what we're going to do today is Terry and Marshall are going to go over some slides for about 15 minutes, and then we have some time for questions as well. So Terry, I hand over to you.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot